Log In
BCIQ
Print this Print this
 

PGxPredict:Warfarin

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionPharmacogentic test to predict patients response to warfarin prescribed after cardiovascular events
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsPredicts patients response to warfarin prescribed after cardiovascular events such as heart attack, stroke and clotting disorders
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today